Douglas Ward

Persistence of HIV in Gut‐Associated Lymphoid Tissue despite Long‐Term Antiretroviral Therapy

Tae‐Wook Chun, David C. Nickle, J. Shawn Justement et al. · The Journal of Infectious Diseases · 2008 · 557 citations · Full text

Primary Immunodeficiency, Human Immunodeficiency Virus, Gut‐associated Lymphoid Tissue +15

Protease inhibitors and cardiovascular outcomes in patients with HIV-1

Scott D. Holmberg, Anne C. Moorman, John Williamson et al. · The Lancet · 2002 · 488 citations

Protease Inhibitors, Thrombosis, Cardiovascular Disease +9

Clinical assessment of HIV-associated lipodystrophy in an ambulatory population

Kenneth A. Lichtenstein, Douglas Ward, Anne C. Moorman et al. · AIDS · 2001 · 426 citations

Obesity, Metabolic Syndrome, Sexual Health +15

Incidence of and Risk Factors for Lipoatrophy (Abnormal Fat Loss) in Ambulatory HIV-1-Infected Patients

Kenneth Lichtenstein, Kathleen M. Delaney, Carl Armon et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2003 · 203 citations

Ambulatory Hiv-1-infected Patients, Obesity, Metabolic Syndrome +19

Switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from dolutegravir plus abacavir and lamivudine in virologically suppressed adults with HIV-1: 48 week results of a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial

Jean‐Michel Molina, Douglas Ward, Indira Brar et al. · The Lancet HIV · 2018 · 192 citations

Treatment And Prevention, Antiviral Drug Development, Clinical Trials +10